Astrocyte elevated gene-1 (AEG-1) is a target gene of oncogenic Ha-ras requiring phosphatidylinositol 3-kinase and c-Myc

被引:202
作者
Lee, Seok-Geun
Su, Zao-Zhong
Emdad, Luni
Sarkar, Devanand
Fisher, Paul B. [1 ]
机构
[1] Columbia Univ, Med Ctr, Coll Phys & Surg, Dept Urol, New York, NY 10032 USA
[2] Columbia Univ, Med Ctr, Coll Phys & Surg, Dept Pathol, New York, NY 10032 USA
[3] Columbia Univ, Med Ctr, Coll Phys & Surg, Dept Neurosurg, New York, NY 10032 USA
[4] Columbia Univ, Med Ctr, Coll Phys & Surg, Herbert Irving Comprehens Canc Ctr, New York, NY 10032 USA
关键词
tumor-promoting gene; signaling pathway; transcription; RAPID SUBTRACTION HYBRIDIZATION; TUMOR-NECROSIS-FACTOR; NF-KAPPA-B; CELL-CYCLE; TRANSCRIPTIONAL REGULATION; SIGNALING PATHWAY; EPITHELIAL-CELLS; PROTEIN-KINASES; BINDING-PROTEIN; CANCER-THERAPY;
D O I
10.1073/pnas.0608386103
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
It is well established that Ha-ras and c-myc genes collaborate in promoting transformation, tumor progression, and metastasis. However, the precise mechanism underlying this cooperation remains unclear. In the present study, we document that astrocyte elevated gene-1 (AEG-1) is a downstream target molecule of Ha-ras and c-myc, mediating their tumor-promoting effects. AEG-1 expression is elevated in diverse neoplastic states, it cooperates with Ha-ras to promote transformation, and its overexpression augments invasion of transformed cells, demonstrating its functional involvement in Ha-ras-mediated tumorigenesis. We now document that AEG-1 expression is markedly induced by oncogenic Ha-ras, activating the phosphatidylinositol 3-kinase signaling pathway that augments binding of c-Myc to key E-box elements in the AEG-1 promoter, thereby regulating AEG-1 transcription. In addition, Ha-ras-mediated colony formation is inhibited by AEG-1 siRNA. This is a demonstration that Ha-ras activation of a tumor-promoting gene is regulated directly by c-Myc DNA binding via phosphatidylinositol 3-kinase signaling, thus revealing a previously uncharacterized mechanism of Ha-ras-mediated oncogenesis through AEG-1.
引用
收藏
页码:17390 / 17395
页数:6
相关论文
共 47 条
[1]   Blocking oncogenic Ras signaling for cancer therapy [J].
Adjei, AA .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2001, 93 (14) :1062-1074
[2]   Oncogenic PI3K deregulates transcription and translation [J].
Bader, AG ;
Kang, SY ;
Zhao, L ;
Vogt, PK .
NATURE REVIEWS CANCER, 2005, 5 (12) :921-929
[3]   Transformation of human and murine fibroblasts without viral oncoproteins [J].
Boehm, JS ;
Hession, MT ;
Bulmer, SE ;
Hahn, WC .
MOLECULAR AND CELLULAR BIOLOGY, 2005, 25 (15) :6464-6474
[4]   C-MYC COOPERATES WITH ACTIVATED RAS TO INDUCE THE CDC2 PROMOTER [J].
BORN, TL ;
FROST, JA ;
SCHONTHAL, A ;
PRENDERGAST, GC ;
FERAMISCO, JR .
MOLECULAR AND CELLULAR BIOLOGY, 1994, 14 (09) :5710-5718
[5]  
BOS JL, 1989, CANCER RES, V49, P4682
[6]   Identification of a novel protein, LYRIC, localized to tight junctions of polarized epithelial cells [J].
Britt, DE ;
Yang, DF ;
Yang, DQ ;
Flanagan, D ;
Callanan, H ;
Lim, YP ;
Lin, SH ;
Hixson, DC .
EXPERIMENTAL CELL RESEARCH, 2004, 300 (01) :134-148
[7]   Metadherin, a cell surface protein in breast tumors that mediates lung metastasis [J].
Brown, DM ;
Ruoslahti, E .
CANCER CELL, 2004, 5 (04) :365-374
[8]   Unexpected induction of the human connexin 43 promoter by the Ras signaling pathway is mediated by a novel putative promoter sequence [J].
Carystinos, GD ;
Kandouz, M ;
Alaoui-Jamali, MA ;
Batist, G .
MOLECULAR PHARMACOLOGY, 2003, 63 (04) :821-831
[9]   THE SMALL GTP-BINDING PROTEINS RAC1 AND CDC42 REGULATE THE ACTIVITY OF THE JNK/SAPK SIGNALING PATHWAY [J].
COSO, OA ;
CHIARIELLO, M ;
YU, JC ;
TERAMOTO, H ;
CRESPO, P ;
XU, NG ;
MIKI, T ;
GUTKIND, JS .
CELL, 1995, 81 (07) :1137-1146
[10]   NF-κB mediated IL-6 production by renal epithelial cells is regulated by C-Jun NH2-terminal kinase [J].
de Haij, S ;
Bakker, AC ;
van der Geest, RN ;
Haegeman, G ;
Vanden Berghe, W ;
Aarbiou, J ;
Daha, MR ;
van Kooten, C .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2005, 16 (06) :1603-1611